HomeBiotechnology stocks

Biotechnology stocks

Merck’s Combination Therapy Fails Phase III Lung Cancer Study

Merck’s Combination Therapy Fails Phase III Lung Cancer Study

March 22, 2024

Lilly Teams Up with Amazon to Deliver Drugs Such as Zepbound

Lilly Teams Up with Amazon to Deliver Drugs Such as Zepbound

March 14, 2024

Moderna Stock Surges 9% as Neoantigen Therapy’s Phase II/III Study Progresses

Moderna Stock Surges 9% as Neoantigen Therapy’s Phase II/III Study Progresses

March 12, 2024

Thermo Fisher Introduces CorEvitas Clinical Registry

Thermo Fisher Introduces CorEvitas Clinical Registry

March 11, 2024

JNJ Receives Full FDA Approval for Rybrevant in Lung Cancer Treatment

JNJ Receives Full FDA Approval for Rybrevant in Lung Cancer Treatment

March 4, 2024

Moderna Exceeds Expectations in Q4 Earnings and Revenue, Maintains Outlook

Moderna Exceeds Expectations in Q4 Earnings and Revenue, Maintains Outlook

February 22, 2024